Dsup pLVX-Puro Citations (3)
Originally described in: Multi-omics Analysis of Dsup Expressing Human Cells Reveals Open Chromatin Architectural Dynamics Underlying RadioprotectionWestover C, Najjar D, Meydan C, Grigorev K, Veling MT, Chang ML, Chin C, Butler D, Afshin EE, Silver PA, Mason CE bioRxiv 2020.11.10.373571 Journal
Articles Citing Dsup pLVX-Puro
| Articles |
|---|
| PIN1 Prolyl Isomerase Promotes Initiation and Progression of Bladder Cancer through the SREBP2-Mediated Cholesterol Biosynthesis Pathway. Wang X, Lee D, Xu H, Sui Y, Meisenhelder J, Hunter T. Cancer Discov. 2025 Mar 3;15(3):633-655. doi: 10.1158/2159-8290.CD-24-0866. PubMed |
| SMARCB1 Deficiency in Tumors Confers Vulnerability to H3K27 Demethylase Inhibitors via Autophagy Disruption. Vilarrubi A, Guillen G, Liu X, Navajas-Chocarro P, Morillas JM, Martinez-Romero A, Diaz CA, Pros E, Altemir-Hervas E, Ezzaanouni A, Fernandez-Serrano M, Roue G, Gomez A, Castillo SD, Vidal A, Carretero J, Martinez-Iniesta M, Soriano A, Moreno L, Villanueva A, Sanchez-Cespedes M, Romero OA. Cancer Res. 2026 Sep 15;86(18):4610-4625. doi: 10.1158/0008-5472.CAN-25-3921. PubMed |
| TRMT1-mediated tRNA m(2)(2)G modification drives Osimertinib resistance via the ATXN3/USP25 axis in lung adenocarcinoma. Li J, Jing B, Wang Y, Bai W, Wei Q, Zhu C, Ling X, Liu M, Huang K, Pan S, Dong H, Lu H, Qian J, Ji Y, Liu W, Zhong H, Zhang Y, Wu W, Zhai Y, Luo H, Lei H, Xu H, Wu Y, Chu T. Cell Death Dis. 2026 Jun 29;17(1):660. doi: 10.1038/s41419-026-09039-8. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.